Tenders/Yantai Central Blood Station Hepatitis B Virus Surface Antigen Diagnostic Reagent Kit (ELISA Method) Procurement Public Tender Announcement

Open🇨🇳ChinaSupplies

Yantai Central Blood Station Hepatitis B Virus Surface Antigen Diagnostic Reagent Kit (ELISA Method) Procurement Public Tender Announcement

Auto-translated from Chinese

Original title: 烟台市中心血站乙型肝炎病毒表面抗原诊断试剂盒（酶联免疫法）采购公开招标公告

烟台市中心血站

Published: Oct 27, 2026

Updated: Oct 27, 2026

Source: China CCGP

About This Opportunity

This is a supplies contract in the health and medical services and general supplies sectors, with a focus on Medical Equipment, Vaccines, Infectious Diseases and Laboratory. Located in China, Asia, this opportunity is open to firms and consortiums.

Published through China CCGP, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. Interested parties should review the full documentation on the original source before submitting their proposal.

Description

Original language: Chinese

The Yantai Blood Center in China is conducting a public tender for the procurement of "Hepatitis B Virus Surface Antigen Diagnostic Reagent Kits (ELISA Method)." Shandong Zhongyu Project Management Consulting Co., Ltd. is the procurement agent. This tender seeks to acquire specific diagnostic kits used for screening blood donations and diagnosing Hepatitis B infections. The Enzyme-Linked Immunosorbent Assay (ELISA) method is a standard and reliable technique for detecting viral antigens. The Yantai Blood Center requires a consistent supply of high-quality, accurate, and sensitive diagnostic kits to ensure the safety of the blood supply and for clinical diagnostic purposes. Typical requirements for such medical diagnostic kits include adherence to strict quality standards (e.g., ISO certifications, national medical device regulations), proven performance characteristics (sensitivity, specificity, accuracy), stability, ease of use, and batch-to-batch consistency. Bidders will be evaluated based on the technical specifications and performance data of their reagent kits, their manufacturing quality systems, pricing, delivery capabilities, and after-sales support. The successful procurement is crucial for public health safety.

Data provenance

This notice is sourced from China CCGP and was originally published on October 27, 2026. Last refreshed today. Original language: Chinese. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About 烟台市中心血站

烟台市中心血站 has issued 10 procurement notices on BidsFactory, including 2 currently open and 0 awarded contracts. Activity concentrates in General Supplies & Services, Health & Medical, and Security, Defense & Justice. All notices are published for China. Notices are distributed via China CCGP. Most recent publication: October 27, 2026.

Frequently asked questions about this tender

How can I submit a bid?

Visit China CCGP to access the full notice, required documents, and submission instructions provided by the contracting authority.

Who is the contracting authority?

This notice was issued by 烟台市中心血站 in China. The authority is responsible for evaluating bids, awarding the contract, and managing performance.

What type of contract is this?

This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.

Where will the contract be performed?

The contract is for delivery in China. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.